A detailed history of Bridger Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bridger Management, LLC holds 41,050 shares of VRTX stock, worth $19 Million. This represents 9.74% of its overall portfolio holdings.

Number of Shares
41,050
Previous 41,050 -0.0%
Holding current value
$19 Million
Previous $19.2 Million 0.77%
% of portfolio
9.74%
Previous 9.9%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $16.7 Million - $18.3 Million
41,050 New
41,050 $17.2 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $1.92 Million - $2.3 Million
5,600 Added 13.21%
48,000 $19.5 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $13.3 Million - $14.9 Million
42,400 New
42,400 $14.9 Million
Q4 2022

Feb 15, 2023

SELL
$285.76 - $321.48 $6.66 Million - $7.49 Million
-23,304 Reduced 58.59%
16,468 $4.76 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $9.12 Million - $10.2 Million
-33,300 Reduced 45.57%
39,772 $11.5 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $2.29 Million - $2.85 Million
-9,728 Reduced 11.75%
73,072 $20.6 Million
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $5.18 Million - $6.11 Million
23,400 Added 39.39%
82,800 $21.6 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $10.5 Million - $13.3 Million
59,400 New
59,400 $13 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bridger Management, LLC Portfolio

Follow Bridger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.